Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS. (Q44018514)

29 November 2017

title

Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS. (English)

1 reference

29 November 2017

Y Hu

1

1 reference

29 November 2017

B Ek-Rylander

series ordinal

2

1 reference

29 November 2017

M Wendel

series ordinal

3

1 reference

29 November 2017

G Andersson

series ordinal

4

1 reference

29 November 2017

publication date

13 November 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

20

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

682-692

1 reference

Bone versus immune system

29 November 2017

cites work

1 reference

Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.

21 January 2018

1 reference

IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.

21 January 2018

1 reference

Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification

21 January 2018

1 reference

Osteoclast differentiation and activation

21 January 2018

1 reference

Interleukin‐4 inhibits RANKL‐induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis

21 January 2018

1 reference

IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints

21 January 2018

1 reference

Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis

21 January 2018

1 reference

Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase

21 January 2018

1 reference

IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

21 January 2018

1 reference

Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts.

21 January 2018

1 reference

Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation

21 January 2018

1 reference

RANKL induces components of the extrinsic coagulation pathway in osteoclasts

21 January 2018

1 reference

Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues

21 January 2018

1 reference

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION.

21 January 2018

1 reference

Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases

21 January 2018

1 reference

Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells

21 January 2018

1 reference

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

21 January 2018

1 reference

Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-γ possibly induced from non-T cell population

21 January 2018

1 reference

RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.

21 January 2018

1 reference

Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis

21 January 2018

1 reference

Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL.

21 January 2018

1 reference

Inflammatory bone destruction and osteoimmunology

21 January 2018

1 reference

New immune connections in osteoclast formation

21 January 2018

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.

21 January 2018

1 reference

IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis

21 January 2018

1 reference

CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts

21 January 2018

1 reference

Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly

21 January 2018

1 reference

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

21 January 2018

1 reference

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ODI.12189

1 reference

29 November 2017

1 reference